<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02096926</url>
  </required_header>
  <id_info>
    <org_study_id>LCR-DEN-01C</org_study_id>
    <nct_id>NCT02096926</nct_id>
  </id_info>
  <brief_title>Methodological Validation of Ibuprofen Verses Placebo for Post Operative Pain After Third Molar Extraction Surgery</brief_title>
  <official_title>Methodological Validation of Ibuprofen Verses Placebo for Post Operative Pain After Third Molar Extraction Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lotus Clinical Research, LLC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lotus Clinical Research, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single center placebo controlled, prospective, randomized study on healthy adults
      undergoing third molar surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sum of pain intensity difference (SPID)6</measure>
    <time_frame>6 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sum of pain intensity difference (SPID) 3</measure>
    <time_frame>3 hour</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Total Pain Relief (TOTPAR) 6</measure>
    <time_frame>6 hours</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Patient Global Assessment</measure>
    <time_frame>6 hours post study drug administration</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Dental Pain</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>400 mg PO</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>400 mg PO</description>
    <arm_group_label>Ibuprofen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who provide written informed consent prior to enrollment

          -  Male or female and 18 to 40 years of age

          -  Patients who are scheduled to undergo elective ipsilateral two (2) third molar
             extraction surgery under local anesthesia The mandibular third molar must involve full
             or partial bony impaction confirmed by radiographic evidence

          -  Female subjects are eligible only if all of the following apply

               -  Not pregnant (subjects of child bearing potential must have a negative urine beta
                  human chorionic gonadotropin (Î²-hCG) pregnancy test before surgery)

               -  Not lactating

               -  Not planning to become pregnant within the duration of the study

          -  Patients who are willing and capable of understanding and cooperating with the
             requirements of the study

          -  Patients able to understand and communicate in English

        Exclusion Criteria:

          -  Patients who have participated in a Lotus Clinical Research placebo response and pain
             scale education training program

          -  Patients with a medical condition that, in the Investigator's opinion, could adversely
             impact the patient's participation, safety, or conduct of the study such as but not
             limited to a history of severe renal or hepatic impairment, severe active hepatic
             disease, other acute or chronic pain conditions, or any other clinically significant
             medical condition

          -  Patients who have a known history of intolerance, severe allergy or hypersensitivity
             to Ibuprofen, opioid analgesics, Lidocaine, or acetaminophen (APAP)

          -  Patients who have abused any prescription medication or alcohol within two years
             before the start of the study

          -  Patients who have surgical complications that could compromise safety of the subject
             or confound the results of the study

          -  The subject is taking any corticosteroid chronically (except for an inhaled steroid
             for pulmonary disease) or has taken systemic corticosteroids within 4 weeks of the
             proposed date of surgery

          -  The subject is taking central nervous system (CNS) active drugs such as
             benzodiazepines, tricyclic antidepressants, selective serotonin reuptake inhibitors
             (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs) for pain. These drugs
             are permitted for non-pain indications throughout the study, if the dose has been
             stable for at least 30 days

          -  The subject has used acetylsalicylic acid, acetaminophen or nonsteroidal
             antiinflammatory drug (NSAIDs) within 5 half-lives prior to the planned day of the
             surgery

          -  The subject is taking an antihypertensive agent(s) or a diabetic regimen at a dose
             that has not been stable for at least 28 days.

          -  Patients who have a history of seizures, or are currently taking anticonvulsants

          -  Patients who have dysphagia and/or cannot swallow study medication whole

          -  Patient who is unable to adequately communicate with study staff, properly give
             informed consent, or otherwise comply with study procedures

          -  Patient who has participated in another clinical trial of an investigational drug or
             device within 30 days of screening visit or is schedule to receive an investigational
             product while participating in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sonia Singla, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lotus Clinical Research, LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lotus Clinical Research, LLC</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <zip>91105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2014</study_first_submitted>
  <study_first_submitted_qc>March 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2014</study_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Third Molar Extraction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Toothache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>April 6, 2018</submitted>
    <returned>May 2, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

